Discontinued — last reported Q4 '23
Business Segments · Malpractice Loss Contingency, Payments, Inception-to-date
Pharma Solutions — Malpractice Loss Contingency, Payments, Inception-to-date
International Flavors & Fragrances Pharma Solutions — Malpractice Loss Contingency, Payments, Inception-to-date remained flat by 0.0% to $46M in Q4 2023 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2023Feb 28, 2024
How to read this metric
Higher cumulative payments indicate significant historical legal risk and potential ongoing liability exposure.
Detailed definition
The cumulative cash payments made by the Pharma Solutions segment to settle legal claims or malpractice-related continge...
Peer comparison
Specific to companies in the pharmaceutical and healthcare supply chain facing product liability risks.
Metric ID:
iff_segment_pharma_solutions_malpractice_loss_contingency_payments_inception_to_dateHistorical Data
4 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|
| Value | $34M | $34M | $46M | $46M |
| QoQ Change | — | +0.0% | +35.3% | +0.0% |
Range$34M – $46M
Current Streak3+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's pharma solutions — malpractice loss contingency, payments, inception-to-date?
- International Flavors & Fragrances (IFF) reported pharma solutions — malpractice loss contingency, payments, inception-to-date of $46M in Q4 2023.
- What does pharma solutions — malpractice loss contingency, payments, inception-to-date mean?
- The total amount paid out over time to settle legal or malpractice claims.